Reduced Diversity of Faecal Microbiota in Crohn's Disease Revealed by a Metagenomic Approach

Overview

Journal Gut

Specialty Gastroenterology

Date 2005 Sep 29

PMID 16188921

Citations 998

Authors

C Manichanh

L Rigottier-Gois

E Bonnaud

K Gloux

E Pelletier

L Frangeul

R Nalin

C Jarrin

P Chardon

P Marteau

J Roca

J Dore

Affiliations

Soon will be listed here.

Abstract

Background And Aim: A role for the intestinal microbial community (microbiota) in the onset and chronicity of Crohn's disease (CD) is strongly suspected. However, investigation of such a complex ecosystem is difficult, even with culture independent molecular approaches.

Methods: We used, for the first time, a comprehensive metagenomic approach to investigate the full range of intestinal microbial diversity. We used a fosmid vector to construct two libraries of genomic DNA isolated directly from faecal samples of six healthy donors and six patients with CD. Bacterial diversity was analysed by screening the two DNA libraries, each composed of 25,000 clones, for the 16S rRNA gene by DNA hybridisation.

Results: Among 1190 selected clones, we identified 125 non-redundant ribotypes mainly represented by the phyla Bacteroidetes and Firmicutes. Among the Firmicutes, 43 distinct ribotypes were identified in the healthy microbiota, compared with only 13 in CD (p<0.025). Fluorescent in situ hybridisation directly targeting 16S rRNA in faecal samples analysed individually (n=12) confirmed the significant reduction in the proportion of bacteria belonging to this phylum in CD patients (p<0.02).

Conclusion: The metagenomic approach allowed us to detect a reduced complexity of the bacterial phylum Firmicutes as a signature of the faecal microbiota in patients with CD. It also indicated the presence of new bacterial species.

Citing Articles

Gut microbiome reveals the trophic variation and significant adaption of three sympatric forest-dwelling ungulates on the eastern Qinghai-Xizang Plateau.

Zhang H, Wang Y, Luo Z, Zhang B, Lan X, Xu L BMC Microbiol. 2025; 25(1):128.

PMID: 40069605 PMC: 11895240. DOI: 10.1186/s12866-025-03812-z.

Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities.

Iliev I, Ananthakrishnan A, Guo C Nat Rev Microbiol. 2025; .

PMID: 40065181 DOI: 10.1038/s41579-025-01163-0.

Microbial dynamics of acute pancreatitis: integrating culture, sequencing, and bile impact on bacterial populations and gaseous metabolites.

Chmielarczyk A, Golinska E, Tomusiak-Plebanek A, Zeber-Lubecka N, Kulecka M, Szczepanik A Front Microbiol. 2025; 16:1544124.

PMID: 40012789 PMC: 11860950. DOI: 10.3389/fmicb.2025.1544124.

Gut microbiota dysfunction in Crohn's disease.

Buffet-Bataillon S, Durao G, Le Huerou-Luron I, Rue O, Le Cunff Y, Cattoir V Front Cell Infect Microbiol. 2025; 15:1540352.

PMID: 40007605 PMC: 11850416. DOI: 10.3389/fcimb.2025.1540352.

Comparative analysis of dominant gut microbiota in Inflammatory Bowel Disease patients and healthy individuals: A case-control study.

Ahmadi A, Kouhsari E, Razavi S, Mohamadzadeh N, Besharat S, Vakili M New Microbes New Infect. 2025; 64:101567.

PMID: 39991465 PMC: 11846925. DOI: 10.1016/j.nmni.2025.101567.

References

Castresana J . Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis. Mol Biol Evol. 2000; 17(4):540-52. DOI: 10.1093/oxfordjournals.molbev.a026334. View

Sartor R . Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when. Curr Opin Gastroenterol. 2005; 19(4):358-65. DOI: 10.1097/00001574-200307000-00006. View

Stein J, Marsh T, Wu K, Shizuya H, Delong E . Characterization of uncultivated prokaryotes: isolation and analysis of a 40-kilobase-pair genome fragment from a planktonic marine archaeon. J Bacteriol. 1996; 178(3):591-9. PMC: 177699. DOI: 10.1128/jb.178.3.591-599.1996. View

Courtois S, Cappellano C, Ball M, Francou F, Normand P, Helynck G . Recombinant environmental libraries provide access to microbial diversity for drug discovery from natural products. Appl Environ Microbiol. 2003; 69(1):49-55. PMC: 152451. DOI: 10.1128/AEM.69.1.49-55.2003. View

Moore W, Holdeman L . Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol. 1974; 27(5):961-79. PMC: 380185. DOI: 10.1128/am.27.5.961-979.1974. View

Godon J, Zumstein E, Dabert P, Habouzit F, Moletta R . Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis. Appl Environ Microbiol. 1997; 63(7):2802-13. PMC: 168577. DOI: 10.1128/aem.63.7.2802-2813.1997. View

Mangin I, Bonnet R, Seksik P, Rigottier-Gois L, Sutren M, Bouhnik Y . Molecular inventory of faecal microflora in patients with Crohn's disease. FEMS Microbiol Ecol. 2009; 50(1):25-36. DOI: 10.1016/j.femsec.2004.05.005. View

Duncan S, Barcenilla A, Stewart C, Pryde S, Flint H . Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol. 2002; 68(10):5186-90. PMC: 126392. DOI: 10.1128/AEM.68.10.5186-5190.2002. View

Cole J, Chai B, Marsh T, Farris R, Wang Q, Kulam S . The Ribosomal Database Project (RDP-II): previewing a new autoaligner that allows regular updates and the new prokaryotic taxonomy. Nucleic Acids Res. 2003; 31(1):442-3. PMC: 165486. DOI: 10.1093/nar/gkg039. View

10.

Suau A, Bonnet R, Sutren M, Godon J, Gibson G, Collins M . Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol. 1999; 65(11):4799-807. PMC: 91647. DOI: 10.1128/AEM.65.11.4799-4807.1999. View

11.

Ott S, Musfeldt M, Wenderoth D, Hampe J, Brant O, Folsch U . Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004; 53(5):685-93. PMC: 1774050. DOI: 10.1136/gut.2003.025403. View

12.

Hooper L, Gordon J . Commensal host-bacterial relationships in the gut. Science. 2001; 292(5519):1115-8. DOI: 10.1126/science.1058709. View

13.

Tamboli C, Neut C, Desreumaux P, Colombel J . Dysbiosis in inflammatory bowel disease. Gut. 2003; 53(1):1-4. PMC: 1773911. DOI: 10.1136/gut.53.1.1. View

14.

Guarner F, Malagelada J . Gut flora in health and disease. Lancet. 2003; 361(9356):512-9. DOI: 10.1016/S0140-6736(03)12489-0. View

15.

Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P . Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut. 2003; 52(2):237-42. PMC: 1774977. DOI: 10.1136/gut.52.2.237. View

16.

Hayashi H, Sakamoto M, Benno Y . Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol. 2002; 46(8):535-48. DOI: 10.1111/j.1348-0421.2002.tb02731.x. View

17.

Lay C, Rigottier-Gois L, Holmstrom K, Rajilic M, Vaughan E, de Vos W . Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol. 2005; 71(7):4153-5. PMC: 1169042. DOI: 10.1128/AEM.71.7.4153-4155.2005. View

18.

Hold G, Pryde S, Russell V, Furrie E, Flint H . Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. FEMS Microbiol Ecol. 2009; 39(1):33-9. DOI: 10.1111/j.1574-6941.2002.tb00904.x. View

19.

Rossello-Mora R, Amann R . The species concept for prokaryotes. FEMS Microbiol Rev. 2001; 25(1):39-67. DOI: 10.1111/j.1574-6976.2001.tb00571.x. View

20.

Barcenilla A, Pryde S, Martin J, Duncan S, Stewart C, Henderson C . Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol. 2000; 66(4):1654-61. PMC: 92037. DOI: 10.1128/AEM.66.4.1654-1661.2000. View